AbbVie Inc. ABBV
$221.59
▲ +1.32% 24H
About
AbbVie Inc. is a research-based biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative medicines and therapies worldwide. The company maintains a strong focus on immunology, offering treatments like Humira, Skyrizi, and Rinvoq for autoimmune and inflammatory conditions in rheuma…
SectorHealthcare
ExchangeNYSE
IndustryDrug Manufacturers - General
CountryUnited States
Employees57,000
TickerABBV
Statistics
Market Cap$391.49B
Revenue (TTM)$61.16B
Net Income$4.23B
Net Margin6.9%
EPS$2.36
P/E109.64
P/S6.32
P/B-60.06
EV/EBITDA15.40
ROE-129.7%
Dividend Yield3.08%
Price$221.59
Data: Twelve Data · Revenue = mcap / P/S